Salisbury et al., 2011 - Google Patents
Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomesSalisbury et al., 2011
View PDF- Document ID
- 15129792392960595237
- Author
- Salisbury A
- Kosiborod M
- Amin A
- Reid K
- Alexander K
- Spertus J
- Masoudi F
- Publication year
- Publication venue
- The American journal of cardiology
External Links
Snippet
New-onset, hospital-acquired anemia (HAA) during acute myocardial infarction (AMI) is independently associated with poor outcomes. The patterns of recovery from HAA after AMI and their association with mortality and health status are unknown. In the prospective 24 …
- 206010000891 Acute myocardial infarction 0 title abstract description 46
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Amin et al. | The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality | |
Lund et al. | Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction | |
Berger et al. | Factors associated with delay in reperfusion therapy in elderly patients with acute myocardial infarction: analysis of the cooperative cardiovascular project | |
Allen et al. | Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure | |
Salisbury et al. | Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes | |
Morrow et al. | Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy | |
Salisbury et al. | Hospital-acquired anemia and in-hospital mortality in patients with acute myocardial infarction | |
Berg et al. | Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials | |
Stähli et al. | Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes | |
Schenkeveld et al. | Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention | |
Palmerini et al. | Comparison of clinical and angiographic prognostic risk scores in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage StrategY (ACUITY) trial | |
Kwok et al. | Relation of frailty to outcomes in patients with acute coronary syndromes | |
Roe et al. | Documented traditional cardiovascular risk factors and mortality in non–ST-segment elevation myocardial infarction | |
Taskesen et al. | Usefulness of mean platelet volume to predict significant coronary artery disease in patients with non–ST-elevation acute coronary syndromes | |
Luther et al. | The relationship between B-type natriuretic peptide and health status in patients with heart failure | |
Helleberg et al. | Mechanisms, predictors and clinical impact of early neurological deterioration: the protocol of the Trondheim early neurological deterioration study | |
Montalescot et al. | Relation of timing of cardiac catheterization to outcomes in patients with non–ST-segment elevation myocardial infarction or unstable angina pectoris enrolled in the multinational Global Registry of Acute Coronary Events | |
Nanchen et al. | Inflammation during acute coronary syndromes—Risk of cardiovascular events and bleeding | |
Amraotkar et al. | Platelet count and mean platelet volume at the time of and after acute myocardial infarction | |
Kontos et al. | Prognostic value of serial N-terminal pro-brain natriuretic peptide testing in patients with acute myocardial infarction | |
Cefalo et al. | A comparison of patients diagnosed with pulmonary embolism who are≥ 65 years with patients< 65 years | |
Araújo et al. | Quality of care and 30-day mortality of women and men with acute myocardial infarction | |
Kwok et al. | Relation of length of stay to unplanned readmissions for patients who undergo elective percutaneous coronary intervention | |
Åkerblom et al. | Albuminuria and cardiovascular events in patients with acute coronary syndromes: results from the TRACER trial | |
Raposeiras-Roubín et al. | Mortality and cardiovascular morbidity within 30 days of discharge following acute coronary syndrome in a contemporary European cohort of patients: how can early risk prediction be improved? the six-month grace risk score |